CSIMarket


Cellectar Biosciences Inc.  (CLRB)
Other Ticker:  
 


 

Cellectar Biosciences Inc.

CLRB's Financial Statements and Analysis



Cellectar Biosciences Inc. increased II. Quarter net loss per share of $-1.22 compare to net loss per share of $-0.11 recorded in the same quarter a year ago a decrease compare to $-0.10 realized in previous quarter.


II. Quarter
Earnings Per Share Revenues
$ -1.22 $  0 Mill
$-1.11     Unch.    



Cellectar Biosciences's Revenue fell by 0 % in II. Quarter (Jun 30 2022) year on year, to $0 million and declined by sequentially.


Cellectar Biosciences is Expected to report next financial results on November 07, 2022.

More on CLRB's Income Statement



Cellectar Biosciences's in II. Quarter recorded net loss of $-7.435 million, an increase from net loss of $-6.028 million in II. Quarter a year ago.

Sequentially company realized net loss, compare to net income of $0.000 million in previous quarter.

More on CLRB's Growth

In II. Quarter company's net cash and cash equivalents decreased by $-6 million, capital expenditures fell by 839.00%, to $-0 millions compare to same quarter a year ago and fell by 136.05% from I. Quarter (Mar 31 2022).

More on CLRB's Cash flow Statement


Cellectar Biosciences Inc. does not pay out common stock dividend.

In trailing twelve-month period Cellectar Biosciences Inc. payed $ -3.56 cash per share, on a free-cash flow basis .

Book value grew by 642.18 % sequentially to $3.31 per share.
Tangible Book value grew to $ 3.08 per share from $ 0.42.

Company repurchased 54.99 million shares or 90.00 % in II. Quarter.


More on CLRB's Dividends

 Market Capitalization (Millions) 21
 Shares Outstanding (Millions) 6
 Total Debt (Millions $) -
 Revenue (TTM) (Millions $) -
 Net Income (TTM) (Millions $) -19
 Cash Flow (TTM) (Millions $) -22
 Capital Exp. (TTM) (Millions $) -0
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ -




Cellectar Biosciences Inc. does not pay out common stock dividend.

In trailing twelve-month period Cellectar Biosciences Inc. payed $ -3.56 cash per share, on a free-cash flow basis .

Book value grew by 642.18 % sequentially to $3.31 per share.
Tangible Book value grew to $ 3.08 per share from $ 0.42.

Company repurchased 54.99 million shares or 90.00 % in II. Quarter.


More on CLRB's Balance Sheets

 Market Capitalization (Millions) 21
 Shares Outstanding (Millions) 6
 Total Debt (Millions $) -
 Revenue (TTM) (Millions $) -
 Net Income (TTM) (Millions $) -19
 Cash Flow (TTM) (Millions $) -22
 Capital Exp. (TTM) (Millions $) -0
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ -


   



       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

CXAC's Profile

Stock Price

CXAC's Financials

Business Description

Fundamentals

Charts & Quotes

CXAC's News

Suppliers

CXAC's Competitors

Customers & Markets

Economic Indicators

CXAC's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright Š 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071